Comparison of high-dose intravenous immunoglobulin ( IVIG) in a 5% and a 10% solution does not reveal a significantly different spectrum of side-effects.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2016, v. 30, n. 12, p. e186, doi. 10.1111/jdv.13496

By:

• Rappold, L.C.;
• Denk, K.;
• Enk, A.H.;
• Hadaschik, E.N.

Publication type:

Article